Added value of 68Ga-PSMA PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer and a previous 99mTc bone scintigraphy

Overview of attention for article published in EJNMMI Research, April 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 8 X users

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 41 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 38 publications that cite this research output.

38

The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.

Equivocal bone lesions on PSMA PET/CT: systematic review and meta-analysis on their prevalence and malignancy rate

Article in Clinical and Translational Imaging (March 2024)

Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases

Article in Nuclear Medicine and Biology (February 2024)

First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients

Article in European Journal of Nuclear Medicine and Molecular Imaging (January 2024)